Tumor samples play a vital role in oncology for both drug development and clinical diagnostic assay development. These samples are available in various formats, including paraffin-preserved human tumor resections, which form large collections of FFPE cancer samples. However, obtaining matching tissues and biofluids for immuno-oncology or diagnostics purposes can be challenging.
To address this issue, Labtoo offers a bespoke service to help Labs, Biotechs, Medtech, and Pharma companies acquire the required samples.
Our tailored mission involves searching for any type of cancer biospecimens from humans, such as fresh tissues, Formalin-Fixed Paraffin-Embedded (FFPE tissues), or frozen tissues. We do not use a catalog solution, which means our team will identify suitable samples already available in sample biobanks or collections, wherever possible, to match the project requirements. Moreover, we can also initiate a prospective clinical collection when needed. Choose Labtoo for reliable and customized cancer biospecimens procurement services.
Please answer the fields below to be contacted by our team of scientists
In cancer treatment research and development, selecting the right research model is essential for obtaining accurate and reliable results. A good research model should mimic the biological and genetic characteristics of human cancers as closely as possible, as well as provide a platform for studying the efficacy and safety of new cancer treatments.
Animal models, such as mice and rats, are commonly used in cancer research as they share many similarities with humans in terms of cancer development and drug metabolism. However, the use of animal models has its limitations, as they may not fully capture the complexity of human cancer biology.
Alternatively, in vitro models, such as cancer cell lines, can provide a controlled environment for studying cancer biology and testing new drugs. These models can be genetically engineered to mimic specific cancer mutations, making them ideal for investigating the molecular mechanisms of cancer development.
In recent years, patient-derived models, such as organoids and patient-derived xenografts, have emerged as promising tools for cancer research. These models use cancer cells from individual patients to create 3D structures that more closely resemble the biology of the original tumor. Patient-derived models are particularly useful for studying tumor heterogeneity and drug resistance, as well as for developing personalized cancer treatments.
Overall, a good research model in cancer treatment R&D should provide a platform for studying the biological and genetic characteristics of human cancers, as well as enable the development of new cancer treatments that are effective, safe, and personalized.
Perform a feasibility study by looking for existing samples already in collections & ready to be transferred
Set up a clinical biological collection and preparing contracts with sources
Assist the material transfer from the source to the lab, including treatments, QA or shipping, as needed